Skip to Main Content
March 21, 2017 at 1:00 PM
BIA-ALCL is a rare condition; when it occurs, it has been identified most frequently in patients undergoing implant revision operations for late onset, persistent seroma.
March 18, 2017 at 10:00 AM
Increased rate of major adverse cardiac events observed in patients receiving the BVS, when compared to patients treated with metallic XIENCE drug-eluting stent.
March 15, 2017 at 12:02 PM
Patients who do not have a gallbladder should not take Viberzi. Developing pancreatitis could result in hospitalization or death.
March 15, 2017 at 12:02 PM
Patients who do not have a gallbladder should not take Viberzi. Developing pancreatitis could result in hospitalization or death.
March 14, 2017 at 1:20 PM
Patients may receive a drug overdose or under dose which can lead to serious adverse health consequences such as respiratory depression, coma or death.
March 14, 2017 at 1:20 PM
Patients may receive a drug overdose or under dose which can lead to serious adverse health consequences such as respiratory depression, coma or death.
March 09, 2017 at 2:23 PM
Device has shut down unexpectedly during patient treatment, which may expose patients to the risk of serious harm or death. Posted 01/14/2017
March 09, 2017 at 2:23 PM
Device has shut down unexpectedly during patient treatment, which may expose patients to the risk of serious harm or death. Posted 01/14/2017
March 09, 2017 at 1:40 PM
Nationwide recall of Regeneca's entire line of herbal and dietary supplement products.
March 09, 2017 at 1:40 PM
Nationwide recall of Regeneca's entire line of herbal and dietary supplement products.
March 09, 2017 at 11:00 AM
Laboratory results confirmed contamination with Pantoea and Enterococcus (intrinsically vancomycin-resistant) bacteria.
March 09, 2017 at 11:00 AM
Laboratory results confirmed contamination with Pantoea and Enterococcus (intrinsically vancomycin-resistant) bacteria.
March 08, 2017 at 1:30 PM
Procedure may put patients at risk because is being promoted as treatment for a variety of conditions even though it has not been formally studied in clinical trials
March 08, 2017 at 1:30 PM
Procedure may put patients at risk because is being promoted as treatment for a variety of conditions even though it has not been formally studied in clinical trials
March 07, 2017 at 8:00 PM
PDE-5 Inhibitors may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels.
March 07, 2017 at 8:00 PM
PDE-5 Inhibitors may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels.
February 27, 2017 at 1:00 PM
Loss of container closure integrity could impact the product’s sterility assurance and may lead to serious adverse events such as infections, both localized at the site of injection and systemically.
February 27, 2017 at 1:00 PM
Loss of container closure integrity could impact the product’s sterility assurance and may lead to serious adverse events such as infections, both localized at the site of injection and systemically.
February 24, 2017 at 8:00 PM
Risk of potential adverse events can range from local site reactions including swelling and inflammation, to allergic reactions which could be life-threatening to users who are sensitive to latex.
February 24, 2017 at 8:00 PM
Risk of potential adverse events can range from local site reactions including swelling and inflammation, to allergic reactions which could be life-threatening to users who are sensitive to latex.
February 22, 2017 at 8:00 AM
Undeclared tadalafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels.
February 22, 2017 at 8:00 AM
Undeclared tadalafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels.
February 16, 2017 at 9:30 AM
Fractures may result in revision surgeries which could cause serious adverse health consequences such as permanent loss of shoulder function, infection, or rarely, death.
February 16, 2017 at 9:30 AM
Fractures may result in revision surgeries which could cause serious adverse health consequences such as permanent loss of shoulder function, infection, or rarely, death.
February 15, 2017 at 8:30 AM
Administration of a drug product intended to be sterile that is not sterile could result in serious infections that may be life-threatening.